These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


117 related items for PubMed ID: 3771860

  • 21. Solitary familial desmoplastic trichoepithelioma. A study by conventional and electron microscopy.
    Dervan PA, O'Hegarty M, O'Loughlin S, Corrigan T.
    Am J Dermatopathol; 1985 Jun; 7(3):277-82. PubMed ID: 4051134
    [Abstract] [Full Text] [Related]

  • 22. A case of basaloid follicular hamartoma.
    Go JW, Oh HE, Cho HK, Kang WH, Ro BI.
    Ann Dermatol; 2010 May; 22(2):229-31. PubMed ID: 20548923
    [Abstract] [Full Text] [Related]

  • 23. Immature trichoepithelioma: report of six cases.
    Long SA, Hurt MA, Santa Cruz DJ.
    J Cutan Pathol; 1988 Dec; 15(6):353-8. PubMed ID: 3220993
    [Abstract] [Full Text] [Related]

  • 24. [Immunohistochemical study of calretinin in normal hair follicles and tumors with follicular differentiation].
    González-Guerra E, Requena L, Kutzner H.
    Actas Dermosifiliogr; 2008 Dec; 99(6):456-63. PubMed ID: 18558053
    [Abstract] [Full Text] [Related]

  • 25. Malignant hair matrix tumor ("malignant trichoepithelioma") arising in the setting of multiple hereditary trichoepithelioma.
    Hunt SJ, Abell E.
    Am J Dermatopathol; 1991 Jun; 13(3):275-81. PubMed ID: 1867358
    [Abstract] [Full Text] [Related]

  • 26. Localized basaloid follicular hamartoma.
    Kato N, Ueno H, Nakamura J.
    J Dermatol; 1992 Oct; 19(10):614-7. PubMed ID: 1491090
    [Abstract] [Full Text] [Related]

  • 27. [A case of generalized komuragaeri disease complicating myasthenia gravis (author's transl)].
    Satoh A, Yoshimura T, Mori M, Tsujihata M, Takamori M.
    Rinsho Shinkeigaku; 1982 Mar; 22(3):251-7. PubMed ID: 7105598
    [No Abstract] [Full Text] [Related]

  • 28. Follicular stem cell marker PHLDA1 (TDAG51) is superior to cytokeratin-20 in differentiating between trichoepithelioma and basal cell carcinoma in small biopsy specimens.
    Sellheyer K, Nelson P.
    J Cutan Pathol; 2011 Jul; 38(7):542-50. PubMed ID: 21352265
    [Abstract] [Full Text] [Related]

  • 29. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O, Lucarini G, Bernardini ML, Simoncini C, Biagini G, Offidani A.
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [Abstract] [Full Text] [Related]

  • 30. Basaloid follicular hamartoma: solitary and multiple types.
    Brownstein MH.
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):237-40. PubMed ID: 1430363
    [Abstract] [Full Text] [Related]

  • 31. "Kissing" basaloid follicular hamartomas of the eyelid.
    Ezemma O, Ragi SD, Ruiz R, Robinson-Bostom L, Enzer Y, DiMarco C.
    J Cutan Pathol; 2022 Oct; 49(10):881-884. PubMed ID: 35699643
    [Abstract] [Full Text] [Related]

  • 32. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
    Katona TM, Ravis SM, Perkins SM, Moores WB, Billings SD.
    Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
    [Abstract] [Full Text] [Related]

  • 33. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
    Sellheyer K, Krahl D.
    Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
    [Abstract] [Full Text] [Related]

  • 34. Trichoepitheliomatous infiltration of the skin simulating leprosy.
    de la Luz Orozco-Covarrubias M, Uribe-Rea C, Tamayo-Sánchez L, Durán-McKinster C, Ruiz-Maldonado R.
    Pediatr Dermatol; 1993 Sep; 10(3):252-5. PubMed ID: 8415302
    [Abstract] [Full Text] [Related]

  • 35. [Desmoplastic trichoepithelioma. Clinical aspects, histology and differential diagnosis].
    Dammert K, Kallioinen M.
    Hautarzt; 1987 Oct; 38(10):603-6. PubMed ID: 3679813
    [Abstract] [Full Text] [Related]

  • 36. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
    Plaza JA, Ortega PF, Bengana C, Stockman DL, Suster S.
    Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
    [Abstract] [Full Text] [Related]

  • 37. Pyridostigmine-Induced Bradycardia in Patient With MuSK-Ab-Positive Myasthenia Gravis and Alopecia Universalis.
    Nazari F, Abdi S.
    J Clin Neuromuscul Dis; 2017 Sep; 19(1):49-50. PubMed ID: 28827491
    [No Abstract] [Full Text] [Related]

  • 38. [Merkel cell carcinoma of the skin in a patient with myasthenia gravis].
    Gianfreda M, Caiffi S, De Franceschi T, Dodero C, Durante R, Faletti P, Rebuttato A, Schivo A, Tassara R.
    Minerva Med; 2002 Jun; 93(3):219-22. PubMed ID: 12094153
    [Abstract] [Full Text] [Related]

  • 39. Bcl-2, CD34 and CD10 expression in basaloid follicular hamartoma, vellus hair hamartoma and neurofollicular hamartoma demonstrate full follicular differentiation.
    Ramos-Ceballos FI, Pashaei S, Kincannon JM, Morgan MB, Smoller BR.
    J Cutan Pathol; 2008 May; 35(5):477-83. PubMed ID: 18399809
    [Abstract] [Full Text] [Related]

  • 40. Cytokeratin expression in trichoblastic fibroma (small nodular type trichoblastoma), trichoepithelioma and basal cell carcinoma.
    Yamamoto O, Asahi M.
    Br J Dermatol; 1999 Jan; 140(1):8-16. PubMed ID: 10215762
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.